N. Galiè, M. Humbert, and J. Vachiery, 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, European Heart Journal, vol.86, issue.(Suppl 1), pp.67-119, 2016.
DOI : 10.1183/09059180.00005412

L. Abenhaim, Y. Moride, and F. Brenot, Appetite-Suppressant Drugs and the Risk of Primary Pulmonary Hypertension, New England Journal of Medicine, vol.335, issue.9, pp.609-625, 1996.
DOI : 10.1056/NEJM199608293350901

D. Montani, A. Seferian, and L. Savale, Drug-induced pulmonary arterial hypertension: a recent outbreak, European Respiratory Review, vol.22, issue.129, pp.244-250, 2013.
DOI : 10.1183/09059180.00003313

F. Breedveld and J. Dayer, Leflunomide: mode of action in the treatment of rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.59, issue.11, pp.841-849, 2000.
DOI : 10.1136/ard.59.11.841

C. Naranjo, U. Busto, and E. Sellers, A method for estimating the probability of adverse drug reactions, Clinical Pharmacology and Therapeutics, vol.30, issue.2, pp.239-284, 1981.
DOI : 10.1038/clpt.1981.154

P. Alvarez, A. Saad, and S. Flagel, Leflunomide-Induced Pulmonary Hypertension in a Young Woman with Rheumatoid Arthritis: A Case Report, Cardiovascular Toxicology, vol.115, issue.2, pp.180-183, 2012.
DOI : 10.7326/0003-4819-115-5-343

V. Martinez-taboada, V. Rodriguez-valverde, and F. Gonzalez-vilchez, Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide, Rheumatology, vol.43, issue.11, pp.1451-1453, 2004.
DOI : 10.1093/rheumatology/keh328

D. Montani, E. Bergot, and S. Günther, Pulmonary Arterial Hypertension in Patients Treated by Dasatinib, Circulation, vol.125, issue.17, pp.2128-2137, 2012.
DOI : 10.1161/CIRCULATIONAHA.111.079921
URL : https://hal.archives-ouvertes.fr/inserm-00697146

S. Pullamsetti, E. Berghausen, and S. Dabral, Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.6, pp.1354-1365, 2012.
DOI : 10.1161/ATVBAHA.112.248500

C. Nagaraj, B. Tang, and Z. Balint, Src tyrosine kinase is crucial for potassium channel function in human pulmonary arteries, European Respiratory Journal, vol.41, issue.1, pp.85-95, 2013.
DOI : 10.1183/09031936.00211811